GT Biopharma Stock (NASDAQ:GTBP), Quotes and News Summary

Q: What sector and industry does GT Biopharma (GTBP) operate in?

GT Biopharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

GT Biopharma Stock (NASDAQ: GTBP) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	0 / 17.909K
Day Range	- - -
52 Wk Range	0.181 - 16.110
Market Cap	$5.633M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	49
Short Interest	0.66%
Days to Cover	1

Recent News

Why Cutera Shares Are Trading Lower By Over 26%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Shares of Cutera, Inc. (NASDAQ: CUTR) fell sharply during Friday’s session after the company reported worse-than-expected fourth quarter adjusted EPS results.

Avi Kapoor

Why State Street Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Gainers PainReform Ltd. (NASDAQ: PRFX) shares climbed 103% to $11.67. PainReform recently announced pricing of a $2.7 million concurrent registered direct offering and private placement.

Lisa Levin

Why Aehr Test Systems Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket

Gainers Ainos, Inc. (NASDAQ: AIMD) shares surged 108.2% to $1.52 in pre-market trading after gaining around 7% on Thursday.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Rating

3.5

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

About GT Biopharma Inc

Sector

Health Care

Industry

Biotechnology

GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commer...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy GT Biopharma (GTBP) stock?

You can purchase shares of GT Biopharma (NASDAQ: GTBP) through any online brokerage.

View our list of the best stock brokerages.

Who are GT Biopharma's (GTBP) competitors?

Other companies in GT Biopharma’s space includes: Alzamend Neuro (NASDAQ:ALZN), Tharimmune (NASDAQ:THAR), Synaptogenix (NASDAQ:SNPX), NexImmune (NASDAQ:NEXI) and Portage Biotech (NASDAQ:PRTG).

What is the target price for GT Biopharma (GTBP) stock?

The latest price target for GT Biopharma (NASDAQ: GTBP) was reported by HC Wainwright & Co. on Tuesday, August 8, 2023. The analyst firm set a price target for 5.00 expecting GTBP to rise to within 12 months (a possible 22.55% upside). 5 analyst firms have reported ratings in the last year.

Current Stock Price for GT Biopharma (GTBP)?

The stock price for GT Biopharma (NASDAQ: GTBP) is $4.08 last updated April 10, 2024 at 9:20 AM EDT.

Does GT Biopharma (GTBP) pay a dividend?

There are no upcoming dividends for GT Biopharma.

When is GT Biopharma (NASDAQ:GTBP) reporting earnings?

GT Biopharma’s Q1 earnings are confirmed for Monday, May 13, 2024.

Is GT Biopharma (GTBP) going to split?

There is no upcoming split for GT Biopharma.

What sector and industry does GT Biopharma (GTBP) operate in?

GT Biopharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-